Fulgent Diagnostics
2011
FOUNDED
PUBLIC
STATUS
91-100
EMPLOYEES
FLGT
STOCK SYMBOL
Description
Provider of cancer drug research services. The company offers cancer drug research, personalized cancer treatments, genetic testing and genetic diagnostic services.
Primary Industry
Other Healthcare Services
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Stock Exchange
NAS
Primary Office
- 4978 Santa Anita Avenue
- Suite 205
- Temple City, CA 91780
- United States
+1 (626) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Fulgent Diagnostics’s full profile, request a free trial.
Fulgent Diagnostics Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Fulgent Diagnostics‘s full profile, request access.
Request full access to PitchBookFulgent Diagnostics Executive Team (3)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Ming Hsieh | Co-Founder, Chairman & Chief Executive Officer | ||
| Paul Kim | Chief Financial Officer | ||
| Harry Gao Ph.D | Chief Scientific Officer & Lab Director |
Fulgent Diagnostics Board Members (1)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 0000 00000 | Fulgent Diagnostics | Co-Founder, Chairman & Chief Executive Officer | 000 0000 |